Featured Videos |view more
Transcranial Magnetic Stimulation for Major Depressive Disorder
Medication isn’t always successful for people with major depressive disorder, but TMS can help. Baron Short, M.D., MSCR, is the medical director for MUSC Health’s Brain Stimulation Service, and he says patients report more energy and an ...
Precision Cranial Reconstruction Using Custom 3D-Printed Skull Prosthesis
MUSC neurosurgeon Nathan Rowland, M.D., Ph.D., shares technical details and sample footage of a unique cranial reconstruction case.
Treating Trigeminal Neuralgia with Microvascular Decompression
Sunil Patel, M.D., the chair of neurosurgery at MUSC, discusses trigeminal neuralgia, a rare condition that causes intense pain in the face when no painful stimuli are present, and its surgical treatment.
Endoscopic Endonasal Resection of Pituitary Tumors
Alexander Vandergrift, M.D., a neurosurgeon at MUSC, describes removing a nonfunctioning pituitary tumor from a patient through endonasal resection using an endoscope.
Deep Brain Stimulation Using a Frameless Platform
Nathan C. Rowland, M.D., Ph.D., a neurosurgeon and assistant professor at MUSC, utilizes a novel, customized frameless platform to perform deep brain stimulation on a patient with essential tremor.
Spinal Cord Repair for Myelomeningocele
Ramin M. Eskandari, M.D., walks through the spinal cord repair surgery for a patient with Myelomeningocele, starting with detethering the spinal cord and laminoplasty and ending with the resection of the epidermoid cyst.
Featured Articles and Documents |view more
Like many neurodegenerative diseases, Parkinson’s disease (PD) is a thief that hacks into human operating systems and corrupts their cognitive hard drives until they can no longer control their movements or perform activities of daily living.
Born on St. Patrick’s Day, Mark George, M.D., peppers his conversation with references to his good fortune.
If you stretched the DNA found in one of your cells from end-to-end, it would extend approximately 2 meters or 6.5 feet.
New Collaboration Technology for Surgeons Improves Stroke Care
As stroke is the 5th leading cause of death in the U.S. according to the Centers for Disease Control and Prevention, physicians are constantly looking for new treatment options and protocol changes.
Putting the Brakes on Heroin Relapse
Neuroscientists from MUSC report in Science Advances that star-shaped brain cells known as astrocytes can “turn off” neurons involved in relapse to heroin use.
Adapting Clinical Trials May Help Reduce Opioid Overdoses in ED
In 2020, nearly 92,000 Americans died due to a drug overdose, and three-quarters of those deaths involved an opioid, according to the Centers for Disease Control and Prevention.
MUSC Health Neurosciences ranks first in the Southeast and second in the country in National Institutes of Health neuroscience research funding. It places researchers and clinicians at each other’s side in an effort to realize the clinical promise of cutting-edge research. As a consistent leader in neuroscience advances, MUSC Health is: